Ginkgo Bioworks Holdings Inc

DNA

Company Profile

  • Business description

    Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

  • Contact

    27 Drydock Avenue
    8th Floor
    BostonMA02210
    USA

    T: +1 877 422-5362

    https://www.ginkgobioworks.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    485

Stocks News & Analysis

stocks

Wide moat stock exchange remains cheap

Aussie stock exchange remains materially undervalued despite growing cost concerns.
stocks

ASX data center player expands pipeline but questions remain

Questions surround Australia’s largest data center developer and its growing pipeline.
stocks

Cheap e-commerce share continues sales momentum

The e-commerce business continues its sales momentum despite challenging backdrop.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,965.0077.800.88%
CAC 408,183.345.53-0.07%
DAX 4025,104.7012.450.05%
Dow JONES (US)51,032.46363.490.72%
FTSE 10010,409.2816.68-0.16%
HKSE25,182.39176.230.70%
NASDAQ26,972.6255.150.20%
Nikkei 22566,329.501,636.382.53%
NZX 50 Index13,244.5538.440.29%
S&P 5007,580.0616.430.22%
S&P/ASX 2008,731.7073.100.84%
SSE Composite Index4,068.5730.07-0.73%

Market Movers